logo

A prospective open-label trial of memantine hydrochloride for the treatment of social deficits in intellectually capable adults with autism spectrum disorder.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Gagan Joshi, Janet Wozniak, Stephen V. Faraone, Ronna Fried, James Chan, Stephannie Furtak, Emily Grimsley, Kristina Conroy, J. Ryan Kilcullen, K. Yvonne Woodworth, Joseph Biederman
Title
A prospective open-label trial of memantine hydrochloride for the treatment of social deficits in intellectually capable adults with autism spectrum disorder.
Journal
Journal of Psychopharmacology
Year
2016
Month
June
Volume
36
Issue
3
Page(s)
pp. 262-271.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Peer-Reviewed, Open Trial
Keywords
Adult, Anxiety, Asperger Syndrome, Attention Deficit Hyperactivity Disorder, Autism, Autistic Disorder, Cognition, Intervention, Medication, Memantine, NMDA receptor antagonists, Pervasive Developmental Disorder (Not Otherwise Specified), Social Skills

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Publications | Publications Database | Search Publications